Next Article in Journal
Quality of Active versus Spontaneous Reporting of Adverse Drug Reactions in Pediatric Patients: Relevance for Pharmacovigilance and Knowledge in Pediatric Medical Care
Next Article in Special Issue
Vascular Effects of the Fetal Hemoglobin Inducer Agent 3-(1,3-Dioxoisoindolin-2-yl) Benzyl Nitrate
Previous Article in Journal
Montelukast and Acute Coronary Syndrome: The Endowed Drug
Previous Article in Special Issue
Looking beyond the Skin: Pathophysiology of Cardiovascular Comorbidity in Psoriasis and the Protective Role of Biologics
 
 
Review

Article Versions Notes

Pharmaceuticals 2022, 15(9), 1145; https://doi.org/10.3390/ph15091145
Action Date Notes Link
article pdf uploaded. 14 September 2022 16:13 CEST Version of Record https://www.mdpi.com/1424-8247/15/9/1145/pdf-vor
article xml file uploaded 15 September 2022 13:14 CEST Original file -
article xml uploaded. 15 September 2022 13:14 CEST Update https://www.mdpi.com/1424-8247/15/9/1145/xml
article pdf uploaded. 15 September 2022 13:14 CEST Updated version of record https://www.mdpi.com/1424-8247/15/9/1145/pdf
article html file updated 15 September 2022 13:15 CEST Original file -
article html file updated 16 September 2022 10:08 CEST Update -
article html file updated 28 February 2023 13:40 CET Update https://www.mdpi.com/1424-8247/15/9/1145/html
Back to TopTop